Surgical Care Update: A Frontiers in Medicine study in China proposes “NMF standards” (intra-op norepinephrine dose, MELD-Na, and total fluids) to better time early renal replacement therapy for acute kidney injury after liver transplant—aiming to improve kidney function and shorten stays. New Implant for Recovery: Nantong University announced a programmable controlled-release bionic spinal cord graft combining five therapeutic components, with animal results reporting improved movement and bladder function over a 12-month study. Obesity Drug Watch: Kailera and Hengrui reported late-stage Phase 3 wins for oral GLP-1 HRS-7535 in China, but Reuters notes very high nausea/vomiting rates in the trial, raising questions about tolerability versus global competitors. Brain & Immune Therapy Research: A review discusses whether extracellular vesicles could become future treatments for multiple sclerosis and systemic lupus erythematosus, though current work is mainly in models. Public Health & Safety: OLAF says more than 200,000 counterfeit condoms from China were sold in Europe, warning they’re untested and could spread sexually transmitted infections. Infectious Disease Surveillance: Researchers compiled a catalog of 239 human-infective RNA viruses, stressing that virus discovery is ongoing and supporting sustained surveillance and preparedness. Health Tech for Sleep: Fullpower-AI says it uses AWS to scale sleep and environment intelligence for smart beds, building on large sleep-data research.